Pneumococcal vaccine and patients with chronic lung disease.

We reviewed data that evaluated both the risk for pneumococcal pneumonia in patients with chronic lung disease and the protection afforded these patients by current pneumococcal vaccines. No conclusive documentation of increased risk for pneumococcal pneumonia in this population exists, and data suggest that the protection provided by the vaccine in healthy persons may be reduced in patients with chronic lung disease. We conclude, on the basis of available data, that routine vaccination of all patients with chronic lung disease is not warranted.

[1]  I. Phillips,et al.  Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. , 1985, British medical journal.

[2]  E. Shapiro,et al.  A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. , 1984, Annals of internal medicine.

[3]  H. Igel,et al.  Evaluation of a latex particle agglutination kit in pneumococcal disease. , 1984, Pediatric infectious disease.

[4]  A. Esposito.  Community-acquired bacteremic pneumococcal pneumonia. Effect of age on manifestations and outcome. , 1984, Archives of internal medicine.

[5]  R. Austrian.  A reassessment of pneumococcal vaccine. , 1984, The New England journal of medicine.

[6]  M. Finland,et al.  Serotypes of Streptococcus pneumoniae isolated from blood cultures at Boston City Hospital between 1979 and 1982. , 1984, The Journal of infectious diseases.

[7]  R. Klein,et al.  Pneumococcal vaccine in the hospital. Improved use and implications for high-risk patients. , 1983, Archives of internal medicine.

[8]  S. Landesman,et al.  Pneumococcal vaccine in elderly patients with COPD. , 1983, Chest.

[9]  R. Roberts,et al.  Effect of underlying disease and age on pneumococcal serotype distribution. , 1983, The American journal of medicine.

[10]  E. Hook,et al.  Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. , 1983, JAMA.

[11]  M. Freedman,et al.  Pneumococcal Bacteremia in Adults , 1983, Journal of the American Geriatrics Society.

[12]  M. Mufson,et al.  Pneumococcal disease in a medium-sized community in the United States. , 1982, JAMA.

[13]  D. Fedson.  Hospital-Based Pneumococcal Immunization: The Epidemiologic Rationale and Its Implementation , 1982, Infection Control.

[14]  J. Schwartz,et al.  Pneumococcal vaccine: clinical efficacy and effectiveness. , 1982, Annals of internal medicine.

[15]  J. Mann,et al.  Pneumococcal pneumonia: experience in a community hospital. , 1982, The Western journal of medicine.

[16]  Benjamin A Lipsky,et al.  Pneumococcal vaccine in the United States. A critical analysis. , 1981, JAMA.

[17]  C. Aranda,et al.  Pneumococcal antibodies in patients with chronic obstructive pulmonary disease and their response to pneumococcal capsular polysaccharides: preliminary results. , 1981, Reviews of infectious diseases.

[18]  R. Austrian.  Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. , 1981, Reviews of infectious diseases.

[19]  J. Mylotte,et al.  Comparison of community-acquired and nosocomial pneumococcal bacteremia. , 1981, The American review of respiratory disease.

[20]  F. R. Woolley,et al.  A cost-benefit analysis of immunization for pneumococcal pneumonia. , 1981, JAMA.

[21]  C. Broome,et al.  Pneumococcal Disease after Pneumococcal Vaccination , 1980 .

[22]  E. Edwards,et al.  Rapid detection of pneumococcal antigens in sputum and blood serum using a coagglutination test. , 1980, Military medicine.

[23]  D. Turk.  Frequencies of pneumococcal types causing serious infections in patients admitted to the Radcliffe Infirmary, Oxford, 1969–77 , 1978, Journal of Hygiene.

[24]  W. Valenti,et al.  Type-specific pneumococcal respiratory disease in the elderly and chronically III. , 1978, The American review of respiratory disease.

[25]  J. Bartlett.  Diagnostic accuracy of transtracheal aspiration bacteriologic studies. , 2015, The American review of respiratory disease.

[26]  R. Douglas,et al.  IMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE Reduction of Adult Respiratory Mortality in a New Guinea Highlands Community , 1977, The Lancet.

[27]  R. Kanner,et al.  Interactions between Viruses and Bacteria in Patients with Chronic Bronchitis , 1976, The Journal of infectious diseases.

[28]  D. Palmer,et al.  Bacteriologic diagnosis of acute pneumonia. Comparison of sputum, transtracheal aspirates, and lung aspirates. , 1976, JAMA.

[29]  M. Mufson,et al.  Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. , 1974, Archives of internal medicine.

[30]  W. Schaffner,et al.  Prospectus: the prevention of bacteremic pneumococcal pneumonia. , 1974 .

[31]  J. Coonrod,et al.  Detection of type-specific pneumococcal antigens by counterimmunoelectrophoresis. I. Methodology and immunologic properties of pneumococcal antigens. , 1973, The Journal of laboratory and clinical medicine.

[32]  J. Matsen,et al.  Host Factors and Capsular Typing of Body Fluid Isolates in Fulminant Pneumococcal Infections , 1972, Infection and immunity.

[33]  E. Barrett-Connor.  The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. , 2015, The American review of respiratory disease.

[34]  M. Schonell,et al.  Pneumococcal typing and the problem of endogenous or exogenous reinfection in chronic bronchitis. , 1971, Lancet.